DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Average Rating of “Hold” from Analysts

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) have earned an average rating of “Hold” from the fourteen research firms that are covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation, ten have issued a hold recommendation and two have given a buy recommendation to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $16.0833.

Several research analysts have issued reports on the company. Weiss Ratings reissued a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research report on Wednesday, October 8th. JPMorgan Chase & Co. decreased their price target on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a report on Friday, November 7th. Evercore ISI lowered their target price on shares of DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating on the stock in a report on Wednesday, October 8th. Barrington Research dropped their target price on shares of DENTSPLY SIRONA from $18.00 to $14.00 and set an “outperform” rating for the company in a research report on Monday, November 10th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of DENTSPLY SIRONA in a report on Friday, September 26th.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of hedge funds have recently made changes to their positions in the company. Arizona State Retirement System grew its stake in DENTSPLY SIRONA by 1.4% during the 3rd quarter. Arizona State Retirement System now owns 58,952 shares of the medical instruments supplier’s stock worth $748,000 after purchasing an additional 807 shares in the last quarter. Public Employees Retirement System of Ohio raised its position in DENTSPLY SIRONA by 1.4% in the 2nd quarter. Public Employees Retirement System of Ohio now owns 61,873 shares of the medical instruments supplier’s stock valued at $983,000 after purchasing an additional 861 shares in the last quarter. Gabelli Funds LLC boosted its stake in shares of DENTSPLY SIRONA by 1.0% in the 1st quarter. Gabelli Funds LLC now owns 98,000 shares of the medical instruments supplier’s stock valued at $1,464,000 after buying an additional 1,000 shares during the period. True Wealth Design LLC grew its position in shares of DENTSPLY SIRONA by 49.7% during the third quarter. True Wealth Design LLC now owns 3,557 shares of the medical instruments supplier’s stock worth $45,000 after buying an additional 1,181 shares in the last quarter. Finally, Sivia Capital Partners LLC grew its position in shares of DENTSPLY SIRONA by 5.3% during the third quarter. Sivia Capital Partners LLC now owns 25,774 shares of the medical instruments supplier’s stock worth $327,000 after buying an additional 1,293 shares in the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Trading Up 0.4%

Shares of NASDAQ:XRAY opened at $11.34 on Monday. The stock’s fifty day moving average price is $12.05 and its 200-day moving average price is $14.08. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11. The company has a market cap of $2.26 billion, a P/E ratio of -2.39, a PEG ratio of 0.81 and a beta of 1.00. DENTSPLY SIRONA has a 1 year low of $9.85 and a 1 year high of $20.59.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 EPS for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.08). DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The company had revenue of $904.00 million during the quarter, compared to the consensus estimate of $900.33 million. During the same quarter in the prior year, the firm earned $0.50 earnings per share. The business’s revenue was down 4.9% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. Sell-side analysts expect that DENTSPLY SIRONA will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.